Background

eMed, Senior M&A Analyst Sept 2022 – present

• Deals. Sources, structures, negotiates and closes acquisitions and strategic investments, leading market, product and financial diligence.
• Chief of Staff to the Executive Chairman, supporting principal-side workstreams across international expansion and portfolio companies.
• Pipeline. Active U.S. and U.K. book across digital health and pharmacy: LOIs, investment memos, comps, teasers, CIMs.
• FP&A. Owns the consolidated deliverables behind the CEO budget and revenue reviews.

Senior M&A Analyst since January 2026; M&A Analyst from September 2022.

ParcelPing, Co-Founder & CEO Remote · Mar 2024 – Oct 2025

• Founded a logistics-technology company building chain-of-custody verification for e-commerce fulfillment and returns.
• Built the team. Eleven people recruited in nine months, largely on equity.
• Went to market. Carrier pilot pursued for AI-enabled package processing. Full account.

Zurn Elkay Water Solutions, M&A Analyst, Corporate Development NYSE: ZWS · Dec 2021 – Aug 2022

• Screened the market. Identified organic growth and acquisition opportunities through market mapping and target screening.
• Ran early process. Led NDA negotiations and drafted LOIs, from outreach through term sheet.

Marquette University, B.S., Business Economics & Finance May 2021

Investment Analysis concentration, through the Applied Investment Management (AIM) program: students research and manage real capital across student-run equity and fixed-income funds, publishing written recommendations and defending them before practitioners.

Published equity research: EnerSys (NYSE: ENS), “Recharging Upside,” AIM Equity Fund, April 2020